SMYD3 and cancer: In recent times, it has been reported that the histone methyltransferase SMYD3 (SET and MYND domain‐containing protein 3) is highly expressed in various human tumors and that overexpression enhances K‐Ras‐associated signaling in cancer cells.4, 5